Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 1
1967 1
1969 1
1970 1
1974 1
1977 1
1978 2
1979 4
1982 1
1983 2
1984 2
1985 3
1986 2
1987 4
1989 1
1990 3
1991 1
1992 5
1993 2
1994 4
1995 3
1996 5
1997 4
1999 9
2000 7
2001 3
2002 2
2003 4
2004 8
2005 2
2006 7
2007 8
2008 12
2009 10
2010 9
2011 13
2012 14
2013 11
2014 17
2015 18
2016 23
2017 23
2018 16
2019 28
2020 44
2021 38
2022 21
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.
Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, Tarsia P, Cattelan A, Comes A, De Laurentiis M, Falcone A, Regge D, Richeldi L, Siena S. Conte P, et al. ESMO Open. 2022 Apr;7(2):100404. doi: 10.1016/j.esmoop.2022.100404. Epub 2022 Feb 24. ESMO Open. 2022. PMID: 35219244 Free PMC article. Review.
CONCLUSIONS: These recommendations provide a structured step-by-step diagnostic and therapeutic approach for each grade of suspected cancer-related DIILD....
CONCLUSIONS: These recommendations provide a structured step-by-step diagnostic and therapeutic approach for each grade of suspected …
The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review.
Ramchatesingh B, Martínez Villarreal A, Arcuri D, Lagacé F, Setah SA, Touma F, Al-Badarin F, Litvinov IV. Ramchatesingh B, et al. Int J Mol Sci. 2022 Oct 20;23(20):12622. doi: 10.3390/ijms232012622. Int J Mol Sci. 2022. PMID: 36293471 Free PMC article. Review.
Retinoids are natural and synthetic vitamin A derivatives that are effective for the prevention and the treatment of non-melanoma skin cancers (NMSC). NMSCs constitute a heterogenous group of non-melanocyte-derived skin cancers that impose substantial burdens on patients a …
Retinoids are natural and synthetic vitamin A derivatives that are effective for the prevention and the treatment of non-melanoma ski …
Novel Peptide Therapeutic Approaches for Cancer Treatment.
Li CM, Haratipour P, Lingeman RG, Perry JJP, Gu L, Hickey RJ, Malkas LH. Li CM, et al. Cells. 2021 Oct 27;10(11):2908. doi: 10.3390/cells10112908. Cells. 2021. PMID: 34831131 Free PMC article. Review.
Peptides are increasingly being developed for use as therapeutics to treat many ailments, including cancer. Therapeutic peptides have the advantages of target specificity and low toxicity. ...Peptides can induce cell death by numerous mechanisms including membrane d …
Peptides are increasingly being developed for use as therapeutics to treat many ailments, including cancer. Therapeutic peptid …
Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions-An Overview of Dermo-Cosmetic and Dermatological Products.
Raszewska-Famielec M, Flieger J. Raszewska-Famielec M, et al. Int J Mol Sci. 2022 Dec 15;23(24):15980. doi: 10.3390/ijms232415980. Int J Mol Sci. 2022. PMID: 36555619 Free PMC article. Review.
We highlighted aspects such as the penetration of NPs through the skin (influence of physical-chemical properties of NPs, the experimental models for skin penetration, methods applied to improve the penetration of NPs through the skin, and methods applied to investigate th …
We highlighted aspects such as the penetration of NPs through the skin (influence of physical-chemical properties of NPs, the experimenta …
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
D'Ambrosio L, Touati N, Blay JY, Grignani G, Flippot R, Czarnecka AM, Piperno-Neumann S, Martin-Broto J, Sanfilippo R, Katz D, Duffaud F, Vincenzi B, Stark DP, Mazzeo F, Tuchscherer A, Chevreau C, Sherriff J, Estival A, Litière S, Sents W, Ray-Coquard I, Tolomeo F, Le Cesne A, Rutkowski P, Stacchiotti S, Kasper B, Gelderblom H, Gronchi A; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. D'Ambrosio L, et al. Cancer. 2020 Jun 1;126(11):2637-2647. doi: 10.1002/cncr.32795. Epub 2020 Mar 4. Cancer. 2020. PMID: 32129883 Free article.
Pembrolizumab for the adjuvant treatment of IIB or IIC melanoma.
Rutkowski P, Czarnecka AM. Rutkowski P, et al. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(9):897-902. doi: 10.1080/14737140.2023.2247565. Epub 2023 Aug 13. Expert Rev Anticancer Ther. 2023. PMID: 37573515 Review.
INTRODUCTION: Up to 30% of patients with stage IIB and 50% of stage IIC melanoma experience recurrence within 5 years after radical surgery. ...Longer follow-up is required to fully understand the efficacy and safety of adjuvant therapy for stage II melanoma, …
INTRODUCTION: Up to 30% of patients with stage IIB and 50% of stage IIC melanoma experience recurrence within 5 years after radical s …
Malignant melanoma in HIV: Epidemiology, pathogenesis, and management.
Facciolà A, Venanzi Rullo E, Ceccarelli M, D'Andrea F, Coco M, Micali C, Cacopardo B, Marino A, Cannavò SP, Di Rosa M, Condorelli F, Pellicanò GF, Guarneri C, Nunnari G. Facciolà A, et al. Dermatol Ther. 2020 Jan;33(1):e13180. doi: 10.1111/dth.13180. Epub 2019 Dec 9. Dermatol Ther. 2020. PMID: 31770477 Review.
In this group of patients, melanoma shows a more aggressive phenotype and poorer survival rates compared to HIV-negative people. ...The aim of this review is to present the current knowledge and future options for melanoma diagnosis and treatment in people living wi …
In this group of patients, melanoma shows a more aggressive phenotype and poorer survival rates compared to HIV-negative people. ...T …
Diagnosis and treatment of melanoma bone metastasis: A multidisciplinary approach.
Caldaria A, Giuffrida R, di Meo N, Massari L, Dianzani C, Cannavò SP, Degrassi F, Casablanca E, Zalaudek I, Conforti C. Caldaria A, et al. Dermatol Ther. 2020 Nov;33(6):e14193. doi: 10.1111/dth.14193. Epub 2020 Sep 10. Dermatol Ther. 2020. PMID: 32790189 Review.
Bone is the fourth most common site of melanoma metastasis after lung, liver, and brain. Melanoma bone metastases typically occur in patients who already have widespread metastases in other organs. Current available approaches for bone metastases from melanoma …
Bone is the fourth most common site of melanoma metastasis after lung, liver, and brain. Melanoma bone metastases typically oc …
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.
Crucitta S, Cucchiara F, Mathijssen R, Mateo J, Jager A, Joosse A, Passaro A, Attili I, Petrini I, van Schaik R, Danesi R, Del Re M. Crucitta S, et al. Cancer Treat Rev. 2022 Mar;104:102340. doi: 10.1016/j.ctrv.2022.102340. Epub 2022 Feb 1. Cancer Treat Rev. 2022. PMID: 35151155 Review.
The present review is focused on tumour heterogeneity and its relation to resistance to targeted-therapy, based on treatment selective pressure across different tumour types, including lung, colorectal, prostate, breast cancer and melanoma. The mechanisms of resista …
The present review is focused on tumour heterogeneity and its relation to resistance to targeted-therapy, based on treatment selectiv …
375 results